Americans for Safe Access

APRIL 15, 2021

Cannabis was listed as a Schedule I substance, a category for “drugs with no currently accepted medical use and a high potential for abuse”; this is a stricter classification than even raw opium, which is Schedule II. Now, two-thirds of Americans live in states where medical cannabis is legal.

Patients 312

Patients Access Medicine Treatment 312

NORML

JUNE 18, 2019

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279

Patients Therapy Data Safety 279

PrestoDoctor

MARCH 4, 2025

Dronabinol, commonly known by its brand name Marinol, is an FDA-approved synthetic form of delta-9-tetrahydrocannabinol (THC) the primary psychoactive component found in cannabis. Used in medical settings, Dronabinol offers relief for patients struggling with chemotherapy-induced nausea, vomiting, and appetite loss associated with HIV/AIDS.

Treatment 93

Treatment THC Patients Conditions 93

Americans for Safe Access

APRIL 3, 2025

Crista Eggers is deeply committed to the advocacy and advancement of medical cannabis legalization in Nebraska. After exhausting all medications and available treatment options for Colton, his doctors mentioned medical cannabis treatment.

Advocacy 166

Advocacy Epilepsy Treatment Education 166

NORML

FEBRUARY 16, 2021

“This study demonstrates that treatment with THC-rich cannabis in patients with mild to moderate UC is associated with clinical improvement.". The post Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis appeared first on NORML.

Clinical Trials 246

Clinical Trials Patients Treatment THC 246

NORML

FEBRUARY 4, 2021

“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".

Clinical Trials 246

Clinical Trials Extraction Patients Treatment 246

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 296

Clinical Trials Chronic Pain Cannabinoids Patients 296

NORML

JANUARY 6, 2023

“Cannabis has established efficacy in the treatment of multiple conditions, including chronic pain, and it possesses a safety profile that is either comparable or superior to other controlled substances. The post Study: Chronic Pain Patients Frequently Report Using Cannabis In Place of Opioids appeared first on NORML.

Chronic Pain 240

Chronic Pain Patients Safety Treatment 240

NORML

JANUARY 24, 2022

"A patient’s treatment options should not be limited by the government, but rather should be determined in confidence between a patient and their doctor. Doctors should be fully empowered to decide what treatment options are best -- free from political interference.".

Patients 246

Patients Treatment Cannabis Marijuana 246

NORML

JUNE 25, 2021

The measure, which NORML opposed, was backed by a number of anti-cannabis organizations, including those opposed to the use of herbal cannabis as a therapeutic treatment in all situations.

Patients 244

Patients Law Treatment Cannabis 244

NORML

DECEMBER 18, 2020

“This study provides evidence that the types of cannabis available in recreational and medical cannabis dispensaries might hold promise as an alternative treatment for PTSD. This study’s primary outcome supports the theory that cannabis should be [tested in clinical trials] as a potential therapeutic for PTSD.".

Clinical Trials 246

Clinical Trials Patients Treatment Dispensary 246

Americans for Safe Access

FEBRUARY 3, 2022

On February 2, 2022, Governor Tate Reeves chose to sign SB 2095 into law, making Mississippi the 37th state to adopt medical cannabis laws. The adoption of these laws is the conclusion of a year-long struggle for the future of cannabis in Mississippi. . ASA strongly opposes both of these provisions.

Access 264

Access Patients Law Agriculture 264

Project CBD

APRIL 17, 2025

Of course, what matters most to patients and clinicians is whether topical and transdermal cannabinoids really work. About nine months earlier, another review by a team of Thai researchers appeared in the journal Cannabis and Cannabinoid Research. A lot of work remains to be done, they write. The findings are mixed.

Topical 178

Topical Medicine CBD Clinical Trials 178

NORML

JANUARY 10, 2024

"A patient’s treatment options should not be limited by the government, but rather, they should be determined in confidence between a patient and their doctor." The post Delaware: House Committee Advances Legislation Expanding Physicians’ Abilities to Authorize Medical Cannabis appeared first on NORML.

Legislation 293

Legislation Treatment Patients Cannabis 293

NORML

APRIL 30, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” ” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients.

Chronic Pain 359

Chronic Pain Clinical Trials Data Patients 359

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments.

Treatment 134

Treatment Cannabinoids Blood Pressure THC 134

Americans for Safe Access

OCTOBER 21, 2020

At ASA, our goal is to ensure that every state has sensible cannabis policies that create safe and legal access for all patients. This means we believe that patients who medicate with cannabis should receive treatment equal to that of patients who medicate with any other drug.

Access 264

Access Patients Programs Treatment 264

NORML

JULY 12, 2021

The lawsuit, which was filed by a 19-year-old patient who uses cannabis for the treatment of severe epilepsy, argues that the proposed changes will unduly restrict medical cannabis access among patients and will discourage physicians from participating in the program.

Epilepsy 246

Epilepsy Legalization Treatment Patients 246

The Cannigma

MARCH 18, 2021

The majority of people with Parkinson’s disease in the United States have not used cannabis to treat their symptoms due to a lack of scientific evidence about its effectiveness. Of those who have used cannabis, most did not receive a recommendation from a doctor or instructions on how to use it, according to the findings of a recent study.

Patients 144

Patients Clinical Trials Treatment Cannabis 144

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 274

Law Patients Access Oil 274

NORML

MARCH 23, 2020

The National Organization for the Reform of Marijuana Laws wishes to reiterate its message that cannabis consumers and others beware of online misinformation surrounding the use of either whole-plant cannabis or CBD as a potential remedy for the COVID-19 virus. Some of these marketers are explicitly targeting cannabis consumers.

CBD 359

CBD Therapy Treatment Packaging 359

The Cannigma

AUGUST 5, 2022

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

Treatment 141

Treatment Research and Development Therapy Digestion 141

MMJ Recs

NOVEMBER 30, 2023

While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. In recent years, there has been growing interest in exploring alternative treatment options, and one that has gained attention is medical marijuana (MMJ).

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Americans for Safe Access

AUGUST 12, 2024

A letter from ASA Founder & President The positive impacts of medical cannabis on patients and the healthcare systems that serve them are profound and far-reaching. Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C.,

Therapy 261

Therapy Pharmaceutical Treatment Programs 261

Illinois News Joint

JANUARY 9, 2025

The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program. For Illinois News Joint reviews, visit here.

Conditions 105

Conditions Treatment Chronic Pain Epilepsy 105

MMJ Recs

JANUARY 2, 2024

In recent years, the landscape of cancer treatment has witnessed a paradigm shift with the emergence of medical cannabis as a potential therapeutic ally. With a rich history of medicinal use, cannabis is garnering attention not only for its palliative effects but also for its potential to target cancer cells directly.

Treatment 98

Treatment Therapy Research and Development Patients 98

NORML

JUNE 1, 2020

House and Senate lawmakers have approved a series of bills to facilitate patients’ access to medical cannabis products. ” Under the current law, doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .” John Bel Edwards.

Access 230

Access Therapy Legislation Patients 230

The Cannigma

MARCH 25, 2021

Like many people who are drawn to work with and advocate for medical cannabis , I first saw the difference that cannabis can make with someone very close to me. The more I read about it, the more I became fascinated with the chemistry and potential of cannabis. I remain in awe of these patients to this day.

Patients 145

Patients Clinical Trials Medicine Events 145

Americans for Safe Access

JULY 29, 2020

Oregon is one of the few but growing number of states that have both a medical cannabis program and an adult use (recreational) program, and users of cannabis medicine can be found in either group. Of course having the conversation about cannabis can be complicated, intimidating and nerve racking.

Programs 246

Programs Therapy Medicine Patients 246

LifeCannMD

MARCH 31, 2025

Fernando Fandino-Sende – Miami’s Top Cannabis Doctor, we understand that seeking medical cannabis treatment is more than a clinical decisionit’s a deeply personal journey toward wellness, often undertaken after considerable reflection and other failed interventions.

Treatment 80

Treatment Chronic Pain History Conditions 80

NORML

JUNE 11, 2019

Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs. Several peer-reviewed studies now document this trend. These conclusions are hardly unique.

Chronic Pain 217

Chronic Pain Programs Patients Access 217

LifeCannMD

APRIL 30, 2025

#image_title First-time Medical Marijuana patient in Miami? You will receive an approval email from the state, which allows you to be legally able to visit any of the states dispensaries or call a medical marijuana treatment center to arrange for delivery the day of your appointment. No more waiting for the card to come in.

Patients 52

Patients Dispensary Marijuana Tincture 52

LifeCannMD

JULY 3, 2024

#image_title Medical Marijuana is becoming a widely used treatment for anxiety and mood disorders like PTSD (Post-Traumatic Stress Disorder). Reduction of Anxiety: CBD is known for its anxiolytic (anxiety-reducing) properties, which can help reduce general anxiety and stress levels in PTSD patients.

Treatment 96

Treatment Clinical Trials Marijuana Sleep 96

Medical Marijuana Pages

JANUARY 7, 2025

Study Finds CBD Safe and Promising For Breast Cancer Patients. The use of cannabidiol (CBD), a non-psychoactive compound derived from cannabis, is becoming increasingly popular among patients seeking alternative or complementary treatments for chronic conditions, including cancer. Read More

Patients 109

Patients CBD Treatment Conditions 109

NORML

MARCH 14, 2019

In the House, Representative Earl Blumenauer (D-OR), a founder and co-Chair of the Congressional Cannabis Caucus, has reintroduced H.R. 1647 , the Veterans Equal Access Act, which expands medical cannabis access to eligible military veterans. Presently, V.A. It’s past time we provide them with the care they need and deserve.”

Access 256

Access Chronic Pain Treatment Conditions 256

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. As a result, many jurisdictions have begun to legalize cannabis for medical. What is ECS?

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306